By Melissa Myers, JPM CBRN Medical Strategic Communications
Disclaimer: Included references to commercial products does not constitute endorsement by the U.S. Department of Defense or...
Novichoks and Pharmaceutical Based Agents
NCT Virtual Hub - May “Novichoks and Pharmaceutical Based Agents (PBAs)” took place on Tuesday, 4 May 2021. Our very...
By Frank G. Rando, CBRNE - Protective and Biomedical Countermeasures SME, University of Arizona
The brilliant Nobel laureate and microbial geneticist, Joshua Lederberg, Ph.D. said...
By Mr. Gde Yulian Yogadhita, Dr. Bella Donna, Gadjah Mada University, Indonesia
As many countries around the globe are preparing to face the second, or...
By Ms. Meghan Treber, MS, ICF, TRACIE Program Director
The mission of the U.S. Department of Health and Human Services (HHS) Office of the Assistant...
By Dr. Stefano Fagiuoli and Dr. Bianca Magro, Hospital of Bergamo
The first coronavirus (COVID-19) cases were identified in Wuhan, Chinain December 2019. Such a...
Chief Technology Officer at the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN MEdical), and advisor tot the JPM CBRN...
Chairman of the NCT Virtual Hub series
The COVID-19 pandemic has demonstrated that biological threats do not respect national borders, treaties, or social/economic status. An...
Shaping the Dutch Response to CBRN Threats through Cooperation and Modernization
By Captain (R) P. (Pepijn) Kuyper, Communications Officer, Defense CBRN Center, Netherlands
The threat for...
How to evaluate the efficiency of a decontamination process in military operations
By Dr. Nikolaus Schneider, Head of the CBRN Decontamination Branch at Bundeswehr Research...
By Jerry Crow, RN, Disaster Program Manager Mobile Medical System, Pharmaceutical Cache and CHEMPAK, Los Angeles County Emergency Medical Services Agency
Most people know that...
